IQV vs MIRA · P/E 23, rev $16.31B vs $41.1M cap
IQVIA Holdings Inc (IQV) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
MIRA does not have a complete income-statement cache yet.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the IQV and MIRA stock pages for the full models.
Not investment advice.